These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 13089911)

  • 1. [Pelentan therapy of thrombophlebitis].
    AFANAS'EVA LM
    Sov Med; 1953 Jul; 17(7):19-20. PubMed ID: 13089911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the treatment of thrombophlebitis with simultaneous application of pelentan and vitamin E].
    BRUCKNEROVA O
    Lek List; 1952 Nov; 7(22):549-52. PubMed ID: 13012120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tromexan therapy of thrombophlebitis].
    VUILLEUMIER P
    Praxis; 1952 Aug; 41(35):758-60. PubMed ID: 13003888
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of tromexan in thrombophlebitis; two years of experience in the Clinique de la Source, in Lausanne].
    VUILLEUMIER P
    Rev Med Suisse Romande; 1953 Jan; 73(1):62-3. PubMed ID: 13075359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hazards in pelentan therapy].
    PAMPURIK E
    Lek Obz; 1952 May; 1(1-2):42-5. PubMed ID: 12982049
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with pelentan therapy of acute rheumatism in adults].
    KOLLAR K
    Bratisl Lek Listy; 1952; 32(1-2):31-8. PubMed ID: 13018960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxicity of pelentan in chronic circulatory insufficiency].
    ALEKSANDROW D; ASKANAS Z; OSINSKI T; WIECLAWEK B; WYSZNACKA W
    Kardiol Pol; 1954; 1(1-2):60-6. PubMed ID: 13272292
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on anticoagulants; pelentan metabolites in human and rabbit urine].
    PROCHAZKA Z
    Cesk Farm; 1952; 1(11-12):637-46. PubMed ID: 13033003
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pelentan therapy in puerperal thrombosis].
    SZINNYAI M; VARJASI F; TREIT S; HUNKA R
    Magy Noorv Lapja; 1955 Nov; 18(6):351-60. PubMed ID: 13287319
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemical characteristics of the main product of anticoagulant pelentan in human urine].
    FUCIK K; HAIS IM; KAKAC B; KNOBLOCH E; PROCHAZKA Z
    Cesk Fysiol; 1955 Jul; 4(3):342-8. PubMed ID: 13276975
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical characterization of the main metabolic product of the anticoagulant drug, pelentan, in human urine.
    FUCIK K; HAIS IM; KAKAC B; KNOBLOCH E; PROCHAZKA Z
    Chekh Fiziol; 1955; 4(3):308-15. PubMed ID: 13330094
    [No Abstract]   [Full Text] [Related]  

  • 13. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethyl biscoumacetate as an inhibitor of sickling.
    GRIFFITHS FE
    Lancet; 1955 Jul; 269(6879):20-1. PubMed ID: 14382604
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions].
    PANCONESI E
    Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of thrombophlebitis.
    OWENS FM
    Minn Med; 1952 Dec; 35(12):1119-22. PubMed ID: 13013076
    [No Abstract]   [Full Text] [Related]  

  • 19. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reaction determining blood prothrombin activity and control of pelentan therapy from the practical viewpoint].
    LIBANSKY J; DIENSTBIER Z; POLAK B
    Cas Lek Cesk; 1951 Aug; 90(35):1039-45. PubMed ID: 14879385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.